2021 ACR适宜性标准:外阴癌的分期和随访

2021-05-10 美国放射学会 J Am Coll Radiol.2021 May;18(5S):S212-S228.

外阴癌是一种少见的妇科肿瘤,也是HPV相关的恶性肿瘤之一。鳞状细胞癌是其最常见的组织学类型,影像学检查在外阴癌的管理中起着重要的作用。本文主要总结了外阴癌各个阶段合理使用影像学检查的建议。

中文标题:

2021 ACR适宜性标准:外阴癌的分期和随访

英文标题:

ACR Appropriateness Criteria® Staging and Follow-up of Vulvar Cancer

发布机构:

美国放射学会

发布日期:

2021-05-10

简要介绍:

外阴癌是一种少见的妇科肿瘤,也是HPV相关的恶性肿瘤之一。鳞状细胞癌是其最常见的组织学类型,影像学检查在外阴癌的管理中起着重要的作用。本文主要总结了外阴癌各个阶段合理使用影像学检查的建议。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 ACR适宜性标准:外阴癌的分期和随访.pdf)] GetToolGuiderByIdResponse(projectId=1, id=a2a201c002101a56, title=2021 ACR适宜性标准:外阴癌的分期和随访, enTitle=ACR Appropriateness Criteria® Staging and Follow-up of Vulvar Cancer, guiderFrom=J Am Coll Radiol.2021 May;18(5S):S212-S228., authorId=0, author=, summary=外阴癌是一种少见的妇科肿瘤,也是HPV相关的恶性肿瘤之一。鳞状细胞癌是其最常见的组织学类型,影像学检查在外阴癌的管理中起着重要的作用。本文主要总结了外阴癌各个阶段合理使用影像学检查的建议。, cover=https://img.medsci.cn/2021518/1621305514139_2020535.jpg, journalId=0, articlesId=null, associationId=191, associationName=美国放射学会, associationIntro=美国放射学会(American College of Radiology)拥有会员超过34,000名,包括美国放射医师,放射肿瘤学家,物理学家介入医师及核医学医师。其指南按放射检查的方法分类,共十组,每组下包括指南十余篇。同时向NGC提供了近200篇指南。学会拥有《ACR Bulletin》及《JACR》两本官方期刊。, copyright=0, guiderPublishedTime=Mon May 10 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>外阴癌是一种少见的妇科肿瘤,也是HPV相关的恶性肿瘤之一。鳞状细胞癌是其最常见的组织学类型,影像学检查在外阴癌的管理中起着重要的作用。本文主要总结了外阴癌各个阶段合理使用影像学检查的建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=39029, tagName=外阴癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=40, categoryName=影像放射, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=39029, guiderKeyword=外阴癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6359, appHits=73, showAppHits=0, pcHits=534, showPcHits=6286, likes=0, shares=7, comments=5, approvalStatus=1, publishedTime=Tue May 18 10:40:22 CST 2021, publishedTimeString=2021-05-10, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Tue May 18 10:38:44 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Thu Jan 04 11:07:09 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 ACR适宜性标准:外阴癌的分期和随访.pdf)])
2021 ACR适宜性标准:外阴癌的分期和随访.pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1053298, encodeId=d060105329891, content=很好的标准。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89bb5611836, createdName=ms2000001043762910, createdTime=Mon Sep 20 17:42:27 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999409, encodeId=f091999409f8, content=q, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dad22541045, createdName=12520089m65暂无昵称, createdTime=Wed Jul 14 15:12:17 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967330, encodeId=89e796e3303a, content=好指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc905505382, createdName=ms8000000769818805, createdTime=Thu May 20 22:16:56 CST 2021, time=2021-05-20, status=1, ipAttribution=)]
    2021-09-20 ms2000001043762910

    很好的标准。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1053298, encodeId=d060105329891, content=很好的标准。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89bb5611836, createdName=ms2000001043762910, createdTime=Mon Sep 20 17:42:27 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999409, encodeId=f091999409f8, content=q, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dad22541045, createdName=12520089m65暂无昵称, createdTime=Wed Jul 14 15:12:17 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967330, encodeId=89e796e3303a, content=好指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc905505382, createdName=ms8000000769818805, createdTime=Thu May 20 22:16:56 CST 2021, time=2021-05-20, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1053298, encodeId=d060105329891, content=很好的标准。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89bb5611836, createdName=ms2000001043762910, createdTime=Mon Sep 20 17:42:27 CST 2021, time=2021-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999409, encodeId=f091999409f8, content=q, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dad22541045, createdName=12520089m65暂无昵称, createdTime=Wed Jul 14 15:12:17 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967330, encodeId=89e796e3303a, content=好指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc905505382, createdName=ms8000000769818805, createdTime=Thu May 20 22:16:56 CST 2021, time=2021-05-20, status=1, ipAttribution=)]
    2021-05-20 ms8000000769818805

    好指南

    0

拓展阅读

2017 ESGO指南:外阴癌患者的管理

欧洲妇科肿瘤学会(ESGO,European Society of Gynecological Oncology) · 2017-04-08

2014 BGCS/RCOG指南:外阴癌的诊断和管理

英国皇家妇产科医师学院(RCOG,Royal College of Obstetricians and Gynaecologists) · 2014-05-01

外阴癌诊断与治疗指南(第四版)

中国抗癌协会妇科肿瘤专业委员会 · 2018-11-02

2022 IGCS共识报告:资源有限地区外阴癌的治疗建议

国际妇科癌症学会(IGCS,International Gynecological Cancer Society) · 2022-09-20

西班牙放射肿瘤学会GINECOR工作组的共识技术指南:外阴癌的放射治疗第二部分——放射治疗建议

西班牙放射肿瘤学会(Spanish Society of Radiation Oncology,SSRO) · 2023-03-24